我科应用珠海生物化学制药厂生产的凝血酶佐治新生儿出血症30例,效果显著,现报告如下。 资料与结果 一、临床资料 对58例临床确诊为新生儿出血症的患儿随机分为治疗组30例和对照组28例,所有患儿均以消化道出血为主要表现(呕血、黑便及大便隐血阳性),均无颅内、肺等重要脏器出血,两组病情、日龄无明显差异。58例均常 My department of Zhuhai biochemical pharmaceutical production of thrombin adjuvant treatment of neonatal hemorrhagic 30 cases, the effect is significant, are as follows. DATA AND RESULT 1. Clinical data 58 children with clinically diagnosed as neonatal hemorrhagic disease were randomly divided into treatment group (n = 30) and control group (n = 28). All of the children had gastrointestinal bleeding as the main manifestation (hematemesis, melena, Stool occult blood positive), no intracranial, pulmonary and other important organs bleeding, two groups of disease, no significant difference in age. 58 cases are common